Cullinan Oncology Inc
NASDAQ:CGEM
Cullinan Oncology Inc
NASDAQ:CGEM
Price:
14.35
USD
0.7%
Market Closed
Market Cap:
$868.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
US |
|
Webuild SpA
MIL:WBD
|
IT |
|
S
|
Seojin System Co Ltd
KOSDAQ:178320
|
KR |
|
D
|
Dalata Hotel Group PLC
F:DHG
|
IE |
|
P
|
Premium Nickel Resources Ltd
XTSX:PNRL
|
CA |
|
ImExHS Ltd
ASX:IME
|
AU |
|
B
|
Beijing Urban-Rural Commercial Group Co Ltd
SSE:600861
|
CN |
|
North Electro-Optic Co Ltd
SSE:600184
|
CN |
|
Zhejiang Meilun Elevator Co Ltd
SSE:603321
|
CN |
|
Alphamin Resources Corp
XTSX:AFM
|
MU |
|
M
|
Mobase Electronics Co Ltd
KOSDAQ:012860
|
KR |
Balance Sheet
Balance Sheet Decomposition
Cullinan Oncology Inc
Cullinan Oncology Inc
Balance Sheet Decomposition is not available for
Cullinan Oncology Inc
Cullinan Oncology Inc
Balance Sheet
Cullinan Oncology Inc
Cullinan Oncology Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
34
|
63
|
168
|
60
|
156
|
98
|
83
|
88
|
|
| Cash Equivalents |
34
|
63
|
168
|
60
|
156
|
98
|
83
|
88
|
|
| Short-Term Investments |
0
|
35
|
42
|
231
|
311
|
369
|
316
|
290
|
|
| Other Current Assets |
0
|
2
|
2
|
6
|
7
|
13
|
16
|
9
|
|
| Total Current Assets |
34
|
100
|
212
|
297
|
475
|
480
|
415
|
387
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
5
|
4
|
2
|
3
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
5
|
4
|
2
|
3
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
140
|
81
|
0
|
204
|
58
|
|
| Other Long-Term Assets |
0
|
0
|
2
|
0
|
1
|
0
|
0
|
0
|
|
| Total Assets |
35
N/A
|
101
+190%
|
215
+114%
|
437
+104%
|
561
+28%
|
484
-14%
|
622
+28%
|
448
-28%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
1
|
10
|
3
|
3
|
2
|
2
|
1
|
|
| Accrued Liabilities |
1
|
2
|
5
|
9
|
15
|
26
|
29
|
37
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
3
|
14
|
12
|
23
|
28
|
31
|
38
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
4
|
2
|
1
|
2
|
|
| Total Liabilities |
1
N/A
|
4
+150%
|
16
+349%
|
12
-22%
|
26
+114%
|
30
+17%
|
31
+3%
|
40
+26%
|
|
| Equity | |||||||||
| Common Stock |
54
|
138
|
277
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
21
|
42
|
93
|
159
|
48
|
201
|
368
|
588
|
|
| Additional Paid In Capital |
0
|
1
|
16
|
585
|
585
|
655
|
959
|
996
|
|
| Other Equity |
0
|
0
|
0
|
1
|
3
|
0
|
0
|
1
|
|
| Total Equity |
33
N/A
|
97
+191%
|
199
+105%
|
425
+114%
|
535
+26%
|
454
-15%
|
590
+30%
|
409
-31%
|
|
| Total Liabilities & Equity |
35
N/A
|
101
+190%
|
215
+114%
|
437
+104%
|
561
+28%
|
484
-14%
|
622
+28%
|
448
-28%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
41
|
40
|
41
|
44
|
46
|
43
|
59
|
60
|
|
| Preferred Shares Outstanding |
0
|
0
|
196
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
